Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01119898 · ClinicalTrials.gov registry record · Phase 2
Exploratory Study of PENNSAID Gel to Treat Symptoms of Knee Osteoarthritis
A Phase 2 study, sponsored by Mallinckrodt.
- Completed
- Registry status
- Phase 2
- Development phase
- 260
- Enrollment target
NCT01119898 is a Phase 2 study that has completed, run by Mallinckrodt. The registered enrollment target is 260 participants.
The verdict
NCT01119898, a Phase 2 study, has completed, sponsored by Mallinckrodt.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 260 participants
- Enrollment target
Study Summary
Osteoarthritis (OA) is the most common form of arthritis. It can cause pain, swelling, and reduced motion in the joints. That can reduce quality of life. OA can occur in any joint, but usually affects the hands, knees, hips or spine. The purpose of this study is to find out if doctors might be able to use 2% PENNSAID gel to treat OA in the knee.
Interventions
- DRUG Vehicle
- DRUG PENNSAID Gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2010-08-02 |
| Est. Completion | 2011-02-16 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01119898
The ClinicalTrials.gov registry entry for NCT01119898 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mallinckrodt, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle is the first listed.
NCT01119898 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01119898 about?
NCT01119898 is a clinical study titled "Exploratory Study of PENNSAID Gel to Treat Symptoms of Knee Osteoarthritis". Osteoarthritis (OA) is the most common form of arthritis. It can cause pain, swelling, and reduced motion in the joints. That can reduce quality of life. OA can occur in any joint, but usually affects the hands, knees, hips or spine. The purpose of this study is to find out if doctors might be abl...
What is the current status of trial NCT01119898?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 260 participants. The study started on 2010-08-02. Estimated completion is 2011-02-16.
What interventions are being tested in trial NCT01119898?
The interventions under investigation include: Vehicle (DRUG), PENNSAID Gel (DRUG).
Who is sponsoring clinical trial NCT01119898?
This trial is sponsored by Mallinckrodt, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.